| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |